Tobira Therapeutics Inc. (TBRA): Pentwater Capital Management Reports New Position

Page 3 of 6 – SEC Filing

1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
PWCM Master Fund Ltd.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
6
SHARED VOTING POWER
7
SOLE DISPOSITIVE POWER
8
SHARED DISPOSITIVE POWER
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,764,901
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
(1) 9.38%
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
*SEE INSTRUCTIONS BEFORE FILLING OUT!
(1)
The percentage reported is based on 18,821,231 shares of Common Stock, par value $0.001 per share outstanding.

Follow Tobira Therapeutics Inc. (NASDAQ:TBRA)